BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32039937)

  • 21. [Muir-Torre syndrome].
    Kudibal MT; Venzo A
    Ugeskr Laeger; 2018 Jul; 180(27):. PubMed ID: 29984696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin lesions with Lynch syndrome could represent Muir-Torre syndrome.
    Siddiqui N; Tariq Z; Gaba C; Hamouda D; Nawras A; Ul Rehman S; Mohamed IE
    Int J Colorectal Dis; 2014 Aug; 29(8):1013-4. PubMed ID: 24793211
    [No Abstract]   [Full Text] [Related]  

  • 24. Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3'UTR of the MSH6 gene.
    Cini G; Carnevali I; Sahnane N; Chiaravalli AM; Dell'Elice A; Maestro R; Pin E; Bestetti I; Radovic S; Armelao F; Viel A; Tibiletti MG
    Cancer Genet; 2021 Jun; 254-255():1-10. PubMed ID: 33516942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.
    Park DM; Yeaney GA; Hamilton RL; Mabold J; Urban N; Appleman L; Flickinger J; Lieberman F; Mintz A
    Neuro Oncol; 2009 Aug; 11(4):452-5. PubMed ID: 19028998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy.
    Guo Z; Cai Y; Yin W; Huang J
    Tumori; 2023 Dec; 109(6):NP27-NP31. PubMed ID: 37880978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.
    Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F
    Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muir-Torre syndrome: a case report and review of the literature.
    Okan G; Vural P; Ince Ü; Yazar A; Uras C; Saruç M
    Turk J Gastroenterol; 2012 Aug; 23(4):394-8. PubMed ID: 22965514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
    Everett JN; Raymond VM; Dandapani M; Marvin M; Kohlmann W; Chittenden A; Koeppe E; Gustafson SL; Else T; Fullen DR; Johnson TM; Syngal S; Gruber SB; Stoffel EM
    JAMA Dermatol; 2014 Dec; 150(12):1315-21. PubMed ID: 25006859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muir-Torre syndrome: a case of unusual coexisting genetic mutations.
    Cino D; Drumm C; Sheahan K; D'Arcy C; Nolan N; Hoti E; Winter D; O'Duffy F; Dolan R; Moriarty B
    Clin Exp Dermatol; 2022 Mar; 47(3):602-604. PubMed ID: 34762321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.
    Georgeson P; Walsh MD; Clendenning M; Daneshvar S; Pope BJ; Mahmood K; Joo JE; Jayasekara H; Jenkins MA; Winship IM; Buchanan DD
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00781. PubMed ID: 31162827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muir-Torre Syndrome: A Case Associated with an Infrequent Gene Mutation.
    Grob A; Feser C; Grekin S
    J Clin Aesthet Dermatol; 2016 Jan; 9(1):56-9. PubMed ID: 26962393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma multiforme in the Muir-Torre syndrome.
    Binder ZA; Johnson MW; Joshi A; Hann CL; Griffin CA; Olivi A; Riggins GJ; Gallia GL
    Clin Neurol Neurosurg; 2011 Jun; 113(5):411-5. PubMed ID: 21288634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sebaceous tumors and Muir-Torre syndrome].
    Bourlond F; Cribier B; Lipsker D; Velter C
    Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
    [No Abstract]   [Full Text] [Related]  

  • 35. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muir-Torre Syndrome: A Case Report in a Woman Without Personal Cancer History.
    Torre K; Ricketts J; Dadras SS
    Am J Dermatopathol; 2019 Jan; 41(1):55-59. PubMed ID: 29933315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sebaceous Carcinoma Arising in Ovarian Teratoma: First Report Associated With Germline Mismatch Repair Gene Mutation.
    Murray J; McIlwaine P; Morrison PJ; McCluggage WG
    Int J Gynecol Pathol; 2022 Nov; 41(6):608-614. PubMed ID: 35077082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report].
    Herr G; Szenes M; Hohl G; Vinkler ME; Tüske G; Horváth J; Nagy G; Tihanyi M; Széll M; Nagy N; Gasztonyi B
    Orv Hetil; 2015 Jun; 156(24):979-84. PubMed ID: 26051134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.